Literature DB >> 7076979

Epidural analgesia or mechanical ventilation for multiple Rib fractures?

M Dittmann, U Steenblock, M Kränzlin, G Wolff.   

Abstract

A protocol for treating thoracic trauma is proposed. Severe pulmonary lesion with increased venous admixture (e.g. contusio, atelectasis, aspiration) is treated by mechanical ventilation. Rib fractures with minor pulmonary lesion and therefore with only moderately abnormal gas exchange but with remarkably reduced vital capacity (even with flail chest) are controlled by thoracic epidural analgesia following vital capacity, tidal volume and respiratory rate. If both a severe pulmonary lesion and serial rib fractures are present, the patient is ventilated for 2-3 days and then extubated to breath spontaneously with epidural analgesia. The indication for a mechanical ventilation or for spontaneous breathing with thoracic epidural analgesia is therefore deducted more from functional variables than from morphological facts. The course of a consecutive series of 283 patients is presented. 155 patients were treated with primary ventilation and 112 patients with primary epidural analgesia, while 16 patients could be managed with general analgesia. The duration of treatment morbidity and mortality show this protocol to be very useful.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076979     DOI: 10.1007/bf01694873

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  9 in total

1.  CLASSIFICATION OF CHEST INJURIES AS AN AID TO TREATMENT.

Authors:  J W LLOYD; A C SMITH; B T O'CONNOR
Journal:  Br Med J       Date:  1965-06-12

2.  Critically crushed chests; a new method of treatment with continuous mechanical hyperventilation to produce alkalotic apnea and internal pneumatic stabilization.

Authors:  E E AVERY; D W BENSON; E T MORCH
Journal:  J Thorac Surg       Date:  1956-09

3.  The basle PEEP weaner. A versatile device for respiratory assistance.

Authors:  M Dittmann; P M Pike; G Wolff
Journal:  Anaesthesia       Date:  1977-06       Impact factor: 6.955

4.  A rationale for epidural analgesia in the treatment of multiple rib fractures.

Authors:  M Dittmann; R Keller; G Wolff
Journal:  Intensive Care Med       Date:  1978-11       Impact factor: 17.440

5.  [Clinical management of the patient with multiple injuries. Indications for priorities and therapeutic plan].

Authors:  G Wolff; M Dittmann; K E Frede
Journal:  Chirurg       Date:  1978-12       Impact factor: 0.955

6.  [Prevention of posttraumatic respiratory insufficiency by coordination of surgery and intensive care (author's transl)].

Authors:  G Wolff; M Dittmann; T Rüedi; B Buchmann; M Allgöwer
Journal:  Unfallheilkunde       Date:  1978-06

7.  Management of bleeding disorders in traumatic-haemorrhagic shock states with deep frozen fresh plasma.

Authors:  H J Hehne; D Nyman; H Burri; G Wolff
Journal:  Eur J Intensive Care Med       Date:  1976

8.  Early and late results of controlled ventilation in flail chest.

Authors:  P Christensson; L Gisselsson; H Lecerof; A J Malm; N M Ohlsson
Journal:  Chest       Date:  1979-04       Impact factor: 9.410

9.  [Therapy of the unstable thorax in serial fractures of the ribs].

Authors:  P Meier; P Schüpbach
Journal:  Schweiz Med Wochenschr       Date:  1978-04-22
  9 in total
  3 in total

1.  Trauma patient adverse outcomes are independently associated with rib cage fracture burden and severity of lung, head, and abdominal injuries.

Authors:  C Michael Dunham; Barbara M Hileman; Kenneth J Ransom; Rema J Malik
Journal:  Int J Burns Trauma       Date:  2015-03-20

2.  Clinical management of blunt trauma patients with unilateral rib fractures: a randomized trial.

Authors:  S G Gabram; R J Schwartz; L M Jacobs; D Lawrence; M A Murphy; J S Morrow; J S Hopkins; R F Knauft
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

3.  Thoracic epidural in the management of chest trauma. A study of 161 cases.

Authors:  L I Worthley
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.